These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7194064)

  • 1. [Interaction of the three alkylating drugs, cyclophosphamide, ifosfamide and trofosfamide, with DNA and DNA-constituents in vitro (author's transl)].
    Lindemann H; Harbers E
    Arzneimittelforschung; 1980; 30(12):2075-80. PubMed ID: 7194064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of three alkylating antimitotic agents and their metabolites on in vitro monogranulocytic colony forming cells from mouse bone marrow.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Arzneimittelforschung; 1981; 31(3):470-3. PubMed ID: 7194671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxazaphosphorine cytostatics on granuloid progenitor cell (CFUc) proliferation in mice.
    Semont H; Hecquet C; Adolphe M; Deysson G
    Exp Hematol; 1982 Oct; 10(9):782-8. PubMed ID: 7173344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
    Norpoth K; Addicks HW; Witting U; Mŭller G; Raidt H
    Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the antimitotic effects of cyclophosphamide, trofosfamide and ifosfamide on meristema plant cells and animal cells in in vitro culture].
    Deysson G; Adolphe M; Semont H
    C R Seances Soc Biol Fil; 1981; 175(2):177-81. PubMed ID: 6454463
    [No Abstract]   [Full Text] [Related]  

  • 6. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapeutic activity of ifosfamide in 6 different isologously transplanted experimental tumours of BD-rats (author's transl)].
    Stekar J
    Arzneimittelforschung; 1976; 26(10):1793-7. PubMed ID: 191035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclophosphamide and ifosfamide on neuroblastoma cells before and after activation by microsomes.
    Meyer T; Wierse G; Weinrebe W; Treuner J; Niethammer D; Bruchelt G
    Anticancer Res; 1997; 17(2A):981-6. PubMed ID: 9137438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disaccharidases of the intestinal mucosa of the rat after cytostatic combined therapy with vincristin sulphate and ifosfamide (author's transl)].
    Hartwich G; Domschke W; Matzkies F
    Arzneimittelforschung; 1976; 26(3):350-2. PubMed ID: 989325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.
    Ellenberger J; Mohn G
    Arch Toxicol; 1975; 33(3):225-40. PubMed ID: 1096853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
    Wagner A; Hempel G; Boos J
    Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
    Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
    J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkylating agents and DNA polymerases.
    Bignold LP
    Anticancer Res; 2006; 26(2B):1327-36. PubMed ID: 16619541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide.
    Mohn GR; Ellenberger J
    Mutat Res; 1976; 32(3-4):331-60. PubMed ID: 822325
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ; Peter G; Struck RF
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of sperm abnormalities in mice by ifosfamide and trofosfamide.
    Quinto I; De Marinis E; De Dominicis G; Della Morte R; Staiano N
    Mutat Res; 1988 Sep; 201(1):113-6. PubMed ID: 3419442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of the splenic cells of different mouse strains to the antiproliferative action of alkylating compounds].
    Pukhal'skiĭ AL; Mezhneva AP; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1988 Feb; 105(2):196-8. PubMed ID: 3349150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of a votile factor from solutions of oxazaphosphorines which damage normal and malignant cells.
    Blomgren H; Hallström M
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):391-7. PubMed ID: 2747340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.